Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) By Investing.com

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635c4

FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that…

www.investing.com

More posts

US bans use of Red No.3 dye in food, drugs over potential cancer links By Reuters

January 16, 2025
Exclusive-Trump team asks three US senior career diplomats to resign, sources say By Reuters

January 16, 2025
Analysts eye Bitcoin rally after bullish CPI print

January 16, 2025
Battlestar Galactica at 20: the show that reinvented space opera

January 16, 2025